Bon Natural Life Limited
BON · NASDAQ
3/31/2025 | 9/30/2024 | 3/31/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $7,950 | $13,661 | $10,184 | $15,372 |
| % Growth | -41.8% | 34.1% | -33.8% | – |
| Cost of Goods Sold | $6,042 | $9,519 | $7,215 | $11,250 |
| Gross Profit | $1,908 | $4,142 | $2,968 | $4,123 |
| % Margin | 24% | 30.3% | 29.1% | 26.8% |
| R&D Expenses | $96 | $730 | $890 | $168 |
| G&A Expenses | $0 | $1,455 | $1,890 | $863 |
| SG&A Expenses | $1,527 | $1,622 | $1,994 | $1,021 |
| Sales & Mktg Exp. | $0 | $167 | $103 | $158 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,624 | $2,353 | $2,884 | $1,189 |
| Operating Income | $284 | $1,789 | $85 | $2,933 |
| % Margin | 3.6% | 13.1% | 0.8% | 19.1% |
| Other Income/Exp. Net | $29 | $0 | -$36 | $9 |
| Pre-Tax Income | $313 | $667 | $49 | $2,942 |
| Tax Expense | $177 | $260 | $91 | $492 |
| Net Income | $169 | $409 | -$11 | $2,476 |
| % Margin | 2.1% | 3% | -0.1% | 16.1% |
| EPS | 0.56 | 0.23 | -0.008 | 2.64 |
| % Growth | 143.5% | 2,904.9% | -100.3% | – |
| EPS Diluted | 0.5 | 0.22 | -0.008 | 2.6 |
| Weighted Avg Shares Out | 303 | 1,781 | 1,286 | 954 |
| Weighted Avg Shares Out Dil | 336 | 1,844 | 1,286 | 942 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $1 |
| Interest Expense | $165 | $160 | $144 | $119 |
| Depreciation & Amortization | $725 | $476 | $686 | $672 |
| EBITDA | $1,203 | $1,302 | $771 | $3,605 |
| % Margin | 15.1% | 9.5% | 7.6% | 23.5% |